Prevalence of Type I IFNs in Plasma and Saliva of Patients With COVID-19 and Association With Clinical Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Heart & Lung
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening
Heart Lung 2024 Sep 01;66(xx)31-36, N Saheb Sharif-Askari, F Saheb Sharif-Askari, OS Bayram, S Hafezi, HAH Alsayed, F Kasim, B Mdkhana, B Selvakumar, HS Alsafar, R HalwaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.